VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $86.00K in the quarter ending March 31, 2026, a decrease of -57.43%. This brings the company's revenue in the last twelve months to $454.00K, down -24.96% year-over-year. In the year 2025, VYNE Therapeutics had annual revenue of $570.00K with 13.77% growth.

• Revenue (ttm): $454.00K
• Revenue Growth: -24.96%
• P/S Ratio: 41.96
• Revenue / Employee: $45,400
• Employees: 10
• Market Cap: 19.05M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	570.00K	69.00K	13.77%
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error